EP Patent

EP0507672B1 — Dérivés de N-cyclohexyl benzamides, leurs préparations et leurs applications en thérapeutique

Assigned to PROMEDICA SA · Expires 1997-06-04 · 29y expired

What this patent protects

Patent listed against tenapanor-hydrochloride.

Drugs covered by this patent

tenapanor-hydrochloride (TENAPANOR HYDROCHLORIDE)

Patent Metadata

Patent number: EP0507672B1
Jurisdiction: EP
Classification: —
Expires: 1997-06-04
Drug substance claim: No
Drug product claim: No
Assignee: PROMEDICA SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.